Company Profiles

driven by the PitchBook Platform

Celtaxsys

Description

Developer of drug compounds for the treatment of inflammatory diseases. The company is engaged in research & development of clinical-stage pharmaceutical and therapeutics drugs to treat inflammatory diseases.

2004

Founded

PRIVATE

Status

1-10

Employees

Series D

Latest Deal Type

$45M

Latest Deal Amount

$60.2M

Total Amount Raised

Description

Developer of drug compounds for the treatment of inflammatory diseases. The company is engaged in research & development of clinical-stage pharmaceutical and therapeutics drugs to treat inflammatory diseases.

Website:

www.celtaxsys.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

201 17th Street Suite 530 Atlanta, GA 30363United States +1 (470) 206-0153
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Celtaxsys's full profile, request a free trial.

    Celtaxsys Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Celtaxsys Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Celtaxsys Investors (10)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Advanced Technology Development CenterAccelerator/IncubatorMinority000 0000000 0000
    Cystic Fibrosis FoundationCorporationMinority000 0000000 0000
    Domain AssociatesVenture CapitalMinority000 0000000 0000
    Evia PartnersOtherMinority000 0000000 0000
    Georgia Research AllianceGovernmentMinority000 0000000 0000
    Advanced Technology Development Center Accelerator/Incubator
    Cystic Fibrosis Foundation Corporation
    Domain Associates Venture Capital
    Evia Partners Other
    Georgia Research Alliance Government

    Celtaxsys Executive Team (6)

    NameTitleBoard
    Seat
    Contact
    Info
    Greg DuncanChief Executive Officer, President and Board Member
    William ReddickChief Financial Officer & Founder
    Eric Springman Ph.DChief Scientific Officer
    Angela WalshController
    Ralph GrosswaldVice President of Operations
    Greg Duncan Chief Executive Officer, President and Board Member
    William Reddick Chief Financial Officer & Founder
    Eric Springman Ph.D Chief Scientific Officer
    Angela Walsh Controller
    Ralph Grosswald Vice President of Operations

    Celtaxsys Board Members (8)

    NameRepresentingRoleSinceContact
    Info
    Gerald BrunkLumira CapitalManaging Director000 0000
    Jan LodalSelfBoard Member000 0000
    Khalil BarrageSelfBoard Member000 0000
    Matthew DontzinSelfBoard Member000 0000
    Maxim GorbachevRusnanoMedInvestManaging Partner000 0000
    Gerald Brunk Managing Director Lumira Capital
    Jan Lodal Board Member Self
    Khalil Barrage Board Member Self
    Matthew Dontzin Board Member Self
    Maxim Gorbachev Managing Partner RusnanoMedInvest
    Request full access to PitchBook